FRANKLIN LAKES, N.J., Oct. 22, 2021 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Dr. Carrie L. Byington has been appointed to the company’s board of directors, bringing the total number of directors to 13. Byington, 58, is executive vice president and head of University of California Health (UCH), where she... Read more
Polen to Succeed Vince Forlenza Effective April 28 FRANKLIN LAKES, N.J., Jan. 26, 2021 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced Tom Polen, BD CEO and president, will assume additional responsibility as chairman of the BD board of directors, effective April 28, 2021. Polen will succeed Vincent A. Forlenza, who... Read more
Automated BD COR™ System Achieves CE-IVD Status; Now Available in Europe Jun 18, 2019 FRANKLIN LAKES, NJ (June 18, 2019) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the CE-IVDD certification of the BD COR™ System in Europe. The high throughput solution for infectious disease diagnostics sets a new standard... Read more
Jun 17, 2019 San Jose, Calif., June 17, 2019 – BD (Becton, Dickinson and Company), a leading global medical technology company, today announced the appointment of Puneet Sarin to worldwide president, BD Biosciences, effective today. In his new role, Puneet will be responsible for driving the global strategic, operational and commercial performance across BD Biosciences while advancing... Read more
BD FACSLyric™ Flow Cytometer is First BD Product to Earn UL Cybersecurity Assurance Program Certification FRANKLIN LAKES, N.J., Dec. 11, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the completion of an enterprise level cybersecurity assessment from UL. This independent assessment evaluates corporate cybersecurity programs and policies to... Read more
Fully-automated BD Phoenix™ CPO Detect Test Receives U.S. FDA Clearance FRANKLIN LAKES, N.J., Nov. 13, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the U.S. Food and Drug Administration 510(k) clearance of the BD Phoenix™ CPO detect test, which will allow hospitals to identify infections caused by carbapenemase-producing organisms (CPOs). The... Read more
Brings Total Company Investment in Nebraska to $340 Million in Two Years COLUMBUS, Neb., Oct. 23, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, was joined today by Gov. Pete Ricketts and other state and local leaders to announce a $200 million investment in its facilities in Nebraska that will create 300 new jobs statewide. Today’s... Read more
Company Joins Effort Alongside Rotary and Leading Global Health Organizations to Expand Vaccinations in India FRANKLIN LAKES, N.J., Oct. 17, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a donation of 20 million syringes valued at $1 million to Rotary, a nonprofit organization dedicated to tackling the world’s most... Read more
BD MAX™ MDR-TB Panel Obtains CE-IVD Status in Europe FRANKLIN LAKES, N.J., Oct. 16, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the availability of the BD MAX™ MDR-TB panel in Europe. Clinicians can use the test to simultaneously detect bacteria that cause tuberculosis (TB) and determine if the bacteria... Read more
Global Medical Technology Company To Be Anchor Tenant at New Campus TEMPE, Ariz., Oct. 3, 2018 /PRNewswire/ — Officials from BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, were joined today by Gov. Doug Ducey, Tempe Mayor Mark Mitchell and representatives of The Boyer Company to officially break ground on the new I.D.E.A. (Innovation, Discovery, Education and Arts)... Read more